Related Experiment Video
Updated: Mar 29, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Prognostic effect of high-flux hemodialysis in patients with chronic kidney disease
1The Hemodialysis Room, Xiangya Hospital of Central South University, Changsha, P.R., China.
Insights
High-flux hemodialysis (HFHD) significantly reduces all-cause and cardiovascular death rates in chronic kidney disease (CKD) patients compared to low-flux hemodialysis (LFHD). HFHD is a recommended therapy choice for CKD patients.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Research
Background:
- Chronic kidney disease (CKD) affects millions globally, necessitating effective dialysis treatments.
- Hemodialysis is a critical intervention for end-stage renal disease.
- Comparing high-flux hemodialysis (HFHD) and low-flux hemodialysis (LFHD) is crucial for optimizing patient outcomes.
Purpose of the Study:
- To investigate the prognostic effects of HFHD versus LFHD in patients with CKD.
- To determine if HFHD offers survival benefits over LFHD.
Main Methods:
- A comprehensive meta-analysis was conducted using data from rigorous literature searches.
- Eight high-quality studies involving 4967 CKD patients (2416 HFHD, 2551 LFHD) were included.
- Quantitative analysis was performed using Comprehensive Meta-analysis 2.0 (CMA 2.0).
Main Results:
- HFHD was associated with a significantly lower all-cause death rate compared to LFHD (OR=0.704, P=0.013).
- HFHD demonstrated a significantly lower cardiovascular death rate than LFHD (OR=0.731, P<0.001).
Conclusions:
- HFHD significantly decreases both all-cause and cardiovascular mortality in CKD patients.
- HFHD should be considered a primary therapeutic option for managing CKD.
Abstract:
We investigated the prognostic effects of high-flux hemodialysis (HFHD) and low-flux hemodialysis (LFHD) in patients with chronic kidney disease (CKD). Both an electronic and a manual search were performed based on our rigorous inclusion and exclusion criteria to retrieve high-quality, relevant clinical studies from various scientific literature databases. Comprehensive meta-analysis 2.0 (CMA 2.0) was used for the quantitative analysis. We initially retrieved 227 studies from the database search. Following a multi-step screening process, eight high-quality studies were selected for our meta-analysis. These eight studies included 4967 patients with CKD (2416 patients in the HFHD group, 2551 patients in the LFHD group). The results of our meta-analysis showed that the all-cause death rate in the HFHD group was significantly lower than that in the LFHD group (OR=0.704, 95%CI=0.533-0.929, P=0.013). Additionally, the cardiovascular death rate in the HFHD group was significantly lower than that in the LFHD group (OR=0.731, 95%CI=0.616-0.866, P<0.001). The results of this meta-analysis clearly showed that HFHD decreases all-cause death and cardiovascular death rates in patients with CKD and that HFHD can therefore be implemented as one of the first therapy choices for CKD.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management

